|
|
||||||||
Investigative Ophthalmology & Visual Science, Vol 25, 787-794, Copyright © 1984 by Association for Research in Vision and Ophthalmology
ARTICLES AND REPORTS |
H Ripps, RE Carr, IM Siegel and VC Greenstein
Various noninvasive test procedures were used to evaluate retinal function in a patient who had become night blind following vincristine chemotherapy. The results obtained were strikingly similar to those reported previously in subjects with recessively inherited stationary night blindness; the dark-adaptation curve was monophasic (ie, no evidence of a scotopic branch), rhodopsin kinetics were entirely normal, and spectral threshold data revealed the presence of residual rod-mediated vision. Also like the heritable condition, the b-wave of the ERG was depressed grossly despite normal a-wave potentials. These findings, and the fact that vincristine is known to disrupt the structural integrity of neuronal microtubules, suggest that the drug- induced defect involves the process of synaptic transmission between the photoreceptors and their second-order neurons.
This article has been cited by other articles:
![]() |
C. Jacobzone, C. Cochard-Marianowski, I. Kupfer, S. Bettembourg, Y. Dordain, L. Misery, B. Cochener, and B. Sassolas Corticosteroid Treatment for Melanoma-Associated Retinopathy: Effect on Visual Acuity and Electrophysiologic Findings Arch Dermatol, October 1, 2004; 140(10): 1258 - 1261. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Alexander, C. S. Barnes, G. A. Fishman, J. Pokorny, and V. C. Smith Contrast-Processing Deficits in Melanoma-Associated Retinopathy Invest. Ophthalmol. Vis. Sci., January 1, 2004; 45(1): 305 - 310. [Abstract] [Full Text] [PDF] |
||||
![]() |
K. R. Alexander, C. S. Barnes, G. A. Fishman, and A. H. Milam Nature of the Cone ON-Pathway Dysfunction in Melanoma-Associated Retinopathy Invest. Ophthalmol. Vis. Sci., April 1, 2002; 43(4): 1189 - 1197. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. W Dawson, B. L Jordan, R. D Marsh, K. Hazariwala, F. P Flowers, and T. Fang Distant cancer effects on standardised testing of peripheral vision Br. J. Ophthalmol., March 1, 2001; 85(3): 291 - 296. [Abstract] [Full Text] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |